Molecules from the same family as the anti-coagulant drug heparin may interfere with the ability of the COVID-19 virus's spikes to bind to human cells. This could be used to treat people with severe ...
Regeneron (NASDAQ:REGN) reported positive Phase 2 data for its thrombosis drug candidates REGN7508 and REGN9933 and plans to initiate Phase 3 testing next year. The company said REGN7508 is designed ...
In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...
QUT PhD researcher Zachariah Schuurs said the research team had identified a new binding site on the SARS-CoV-2 spike protein. "Binding of the CoV-2 spike protein to heparan sulphate (HS) on cell ...
A large drugmaker and a life sciences investment firm have launched a new company that will develop drugs for cardiovascular diseases. Swiss drugmaker Novartis and New York-based Blackstone’s Life ...
NovoSeven RT (coagulation factor VIIa, recombinant) is a brand-name intravenous (IV) infusion prescribed for hemophilia and some other blood disorders. It has interactions with some other drugs, ...
DUBLIN--(BUSINESS WIRE)--The "Anticoagulants Market Global Forecast Report by Drug Class, Route of Administration, Distribution Channel, Application, Countries and Company Analysis 2025-2033" report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results